Homocysteine‐lowering interventions for preventing cardiovascular events

AJ Marti-Carvajal, I Sola, D Lathyris… - Cochrane database of …, 2017 - cochranelibrary.com
Background Cardiovascular disease, which includes coronary artery disease, stroke and
peripheral vascular disease, is a leading cause of death worldwide. Homocysteine is an …

Does folic acid protect patients with inflammatory bowel disease from complications?

AE Ratajczak, A Szymczak-Tomczak, AM Rychter… - Nutrients, 2021 - mdpi.com
Folic acid, referred to as vitamin B9, is a water-soluble substance, which participates in the
synthesis of nucleic acids, amino acids, and proteins. Similarly to B12 and B6, vitamin B9 is …

Changes in total homocysteine levels after acute stroke and recurrence of stroke

Z Shi, S Liu, Y Guan, M Zhang, H Lu, W Yue… - Scientific Reports, 2018 - nature.com
It is not known how total homocysteine (tHcy) levels change during the transition from acute
stroke to post-stroke convalescence or whether tHcy changes occurring after the acute …

VSMC-specific deletion of FAM3A attenuated Ang II-promoted hypertension and cardiovascular hypertrophy

R Xiang, J Chen, S Li, H Yan, Y Meng, J Cai… - Circulation …, 2020 - Am Heart Assoc
Rationale: Dysregulated purinergic signaling transduction plays important roles in the
pathogenesis of cardiovascular diseases. However, the role and mechanism of vascular …

Associations of total homocysteine and kidney function with all-cause and cause-specific mortality in hypertensive patients: a mediation and joint analysis

C Ding, J Li, Y Wei, W Fan, T Cao, Z Chen, Y Shi… - Hypertension …, 2024 - nature.com
Plasma total homocysteine (tHcy) and kidney function are both associated with mortality risk,
but the degree to which kidney function modifies the impact of tHcy on mortality remains …

Hyperhomocysteinemia as a link of chemotherapy-related endothelium impairment

A Avagimyan - Current Problems in Cardiology, 2022 - Elsevier
Atherosclerosis is a well-known risk factor of cardiovascular disease development. This
research presents the AC mode of chemotherapy-related homocysteine level changes, with …

The homocysteine and metabolic syndrome: a Mendelian randomization study

HS Lee, S In, T Park - Nutrients, 2021 - mdpi.com
Homocysteine (Hcy) is well known to be increased in the metabolic syndrome (MetS)
incidence. However, it remains unclear whether the relationship is causal or not. Recently …

Sex differences in risk factors for stroke in patients with hypertension and hyperhomocysteinemia

H Pang, Q Fu, Q Cao, L Hao, Z Zong - Scientific reports, 2019 - nature.com
Data on the sex-specific differences in risk of stroke among patients with H-type
hypertension are limited. We aimed to analyze interactions between sex and other risk …

Association of factor V Leiden R506Q, FXIIIVal34Leu, and MTHFR C677T polymorphisms with acute myocardial infarction

A Golestani, A Rahimi, N Moridi, G Anani-Sarab… - Egyptian Journal of …, 2022 - Springer
Background Acute myocardial infarction (AMI) is a leading cause of death and morbidity
around the world. Although the association between thrombophilia and AMI is well …

[HTML][HTML] Red cell distribution width and homocysteine act as independent risk factors for cardiovascular events in newly diagnostic essential hypertension

LM He, CY Gao, Y Wang, H Wang, HY Zhao - Oncotarget, 2017 - ncbi.nlm.nih.gov
Hyperhomocysteinemia and increased red cell distribution width (RDW) are associated with
a higher possibility of adverse clinical outcomes of hypertension. The study aims to validate …